“I rang the bell again. No one came.”

by Carolyn Thomas    @HeartSisters

There are a number of issues that leaped out at me about the hospital story you’re about to read.  Let’s see how many of them you observe, too – and how many could have been prevented.  This story is told by Ann, an Australian heart patient whose cardiac journey began in 2007 when she was 51 years old. But over the years since then, she has continued to suffer debilitating cardiac symptoms almost every day.

Her symptoms include not just chest pain, but pain throughout her upper back, jaw, shoulder, neck or arm, occasionally with severe shortness of breath. Despite taking a fistful of daily heart meds and wearing a nitro patch to help manage pain, Ann is rarely able to sleep through an entire night without being awoken by these symptoms. And here’s why . . .
Continue reading ““I rang the bell again. No one came.””

Women and statins: evidence-based medicine or wishful thinking?

by Carolyn Thomas    @HeartSisters

Are you:

A.  a healthy woman who’s never had any issues with your heart, but . . .

B you know heart disease is the #1 killer of women, so . . .

C.  you’re wondering what you can do to help prevent B from happening to you?

Warding off a first heart attack for a person with no history of heart disease is what physicians call primary prevention.  Warding off another heart attack for a person who already lives with heart disease is called secondary prevention.  It’s also what respected cardiologists representing both the American Heart Association and the American College of Cardiology are now telling us can be effectively accomplished by taking one of the cholesterol-lowering drugs known as statins.

But it turns out that many other equally-respected cardiologists don’t believe that taking a powerful drug every day for the rest of your natural life for a disease you don’t even have is appropriate for primary prevention – particularly in womenContinue reading “Women and statins: evidence-based medicine or wishful thinking?”

Heart attacks: “Men explode, but women erode”

by Carolyn Thomas  ♥ @HeartSisters

heart-460546_1280Los Angeles cardiologist Dr. Noel Bairey Merz believes that the biggest issue facing women heart patients is that as a society we have been programmed to think of heart disease as a man’s problem. During a presentation in Australia last year, she told her audience:

“The fatty build-up of plaque in a coronary artery causing a heart attack will usually rupture or ‘explode’ in men.

“But in women, it will often be a much smaller, more subtle event, caused by ‘erosion’, not explosion. 

“Often their symptoms may throw doctors off track to the wrong diagnosis, and in many cases, women won’t even know they have had a heart attack until it’s too late.”   .

Continue reading “Heart attacks: “Men explode, but women erode””

How gender bias threatens women’s health

by Carolyn Thomas    ♥   @HeartSisters

I attended the 64th annual Canadian Cardiovascular Congress not as a participant, but with media accreditation in order to report on the proceedings for my blog readers.  I arrived at the gorgeous Vancouver Convention Centre feeling excited to interview as many of the cardiac researchers attending this conference as I could squeeze into my 2-day schedule – particularly all the ones studying women’s heart disease.  I was gobsmacked, however, when conference organizers in the Media Centre told me on my first day that, out of hundreds of cardiology papers being presented that year, I’d be able to “count on one hand” the number of those studies that had anything even remotely to do with the subject of women and heart disease. Essentially, that appalling gender gap then became the Big Story of the conference for me. And every one of those four lonely little studies shared a conclusion that I already knew: when it comes to heart disease, women fare worse than men do.*  See also: The Sad Reality of Women’s Heart Disease Hits Home.

But already, I can tell that this weekend’s annual Congress (once again back in Vancouver) should do better.  This year, the 192-page conference program lists over a dozen studies reporting specifically on women’s experience of heart disease.(1)  Sounds good – until you remember that it’s a puny drop in the bucket for an international conference where over 500 original new scientific papers are being presented about a diagnosis that has killed more women than men every year since 1984. Continue reading “How gender bias threatens women’s health”

Women, controversial statin guidelines, and common sense

by Carolyn Thomas  @HeartSisters

101109expIf you’re a heart patient, I’m betting that you’re already taking one of the cholesterol-lowering drugs called statins. That’s because these drugs – with brand names like Lipitor, Crestor, Zocor or any of their generic forms – are routinely prescribed to those diagnosed with cardiovascular disease. Many studies (largely funded by the drug companies that make statins) suggest that, for heart attack survivors, these drugs may help to significantly lower our risk of having another cardiac event. It’s what doctors call “secondary prevention”.

Some studies further suggest that statins are also useful for those who’ve never had heart disease, but who do have high LDL (or “bad”) cholesterol – what’s called “primary prevention”. But recently, statins hit the front page of The New York Times with a big fat *splat* when new clinical practice guidelines for treating/preventing heart disease were released by the American Heart Association and the American College of Cardiology (both heart organizations that are coincidentally largely funded by drug companies, too). The guidelines essentially said: from now on, forget about your LDL numbers. It’s all about your risk factors now. 

The likely result of this change, as I observed here and here, is the recommendation that, as long as you have a detectable pulse, you need to take statins. 

Continue reading “Women, controversial statin guidelines, and common sense”